Related Experiment Video
Updated: Sep 12, 2025

11:22
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
17.6K
Scaffold-Free Osteochondral Engineering Using Embryonic-Derived Mesenchymal Stem Cell Spheroids
Shawn P Grogan1, Nicholas E Glembotski1, Erik W Dorthé1
1Scripps Health, Shiley Center for Orthopaedic Research and Education at Scripps Clinic, La Jolla, California, USA.
Tissue Engineering. Part A
|August 7, 2025
Summary
Embryonic stem cell-derived mesenchymal stem cell spheroids in a closed chamber system create scaffold-free cartilage and bone graft tissues. This method shows promise for cartilage repair and engineering osteochondral tissues.
Area of Science:
- Regenerative Medicine
- Tissue Engineering
- Stem Cell Biology
Background:
- Cartilage defects and osteochondral injuries pose significant clinical challenges.
- Current tissue engineering strategies often rely on scaffolds, which can have limitations.
- Developing scaffold-free approaches using cellular spheroids offers a promising alternative.
Purpose of the Study:
- To investigate the potential of embryonic stem cell-derived mesenchymal stem cell (ES-MSC) spheroids within a closed chamber system for creating scaffold-free cartilage and endochondral grafts.
- To evaluate the efficacy of these engineered tissues for cartilage repair and osteochondral regeneration.
Main Methods:
- ES-MSC spheroids were cultured in chondrogenic or osteogenic media and then seeded into a customizable Net Mold Chamber System (NCS).
- Constructs were cultured for varying durations to promote cartilage or osteochondral tissue formation.
- Engineered cartilage was implanted into ex vivo human cartilage defects to assess repair potential.
- Osteochondral constructs were analyzed for cartilage and bone matrix production.
Main Results:
- NCS-cultured ES-MSC spheroids formed neocartilage tissues expressing key cartilage markers (COL2A1, ACAN, COMP) and matrix molecules.
- Implanted cartilage constructs integrated with ex vivo osteoarthritic tissue, showing a significant elastic modulus.
- Osteogenic cultures produced mineralized tissues positive for osteopontin.
- Combined chondrogenic and osteogenic cultures in stacked NCS chambers yielded osteochondral neotissues up to 2 mm thick.
Conclusions:
- Scaffold-free cartilage and osteochondral graft tissues can be engineered using ES-MSC spheroids in a closed chamber system.
- This approach demonstrates potential for generating clinically relevant graft tissues for cartilage repair and osteochondral regeneration.
- The use of ES-MSC spheroids in NCS offers a promising scaffold-free strategy for regenerative medicine applications.

